Grace and Molecule.one strike multi-year AI pact to break peptide manufacturing bottlenecks
These building blocks are essential to modern therapeutics, including fast-growing GLP-1 treatments for weight loss and diabetes
These building blocks are essential to modern therapeutics, including fast-growing GLP-1 treatments for weight loss and diabetes
The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
LNK01006 is designed to deliver potent, selective inhibition of TYK2-mediated cytokine signaling with central nervous system exposure
This strategic investment aims to bolster the company's position as a global leader in Vitamin D3 manufacturing
Terray and BMS aim to accelerate small molecule drug discovery by harnessing EMMI’s integrated experimental and AI capabilities
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
The successful refinancing and enhancement of the syndicated credit facilities provides access to an additional CHF 40 million
Subscribe To Our Newsletter & Stay Updated